Boston, MA – – Apnimed, a clinical-stage biopharmaceutical company focused on developing novel therapies for sleep-related breathing disorders, has announced…
Read More
Penn Researchers Develop Breakthrough Non-Addictive Gene Therapy Targeting Brain Pain Circuits to Combat Chronic Pain and Opioid Crisis
A new preclinical study has identified a gene therapy that directly targets pain-processing areas in the brain while avoiding the…
Read More
European Commission Approves Keytruda Combination Therapy for PD-L1-Positive Platinum-Resistant Ovarian Cancer
The European Commission (EC) has granted approval for Keytruda (pembrolizumab) in combination with paclitaxel, with or without bevacizumab, as a…
Read More
Ludwig Cancer Research Study Identifies Novel Combination Therapy to Overcome Differentiation Block in Acute Myelogenous Leukemia
The landscape of hematological oncology is facing a potential paradigm shift following a comprehensive study led by Ludwig Cancer Research,…
Read More
The Court said talk therapy is protected speech, not medical conduct
The United States Supreme Court, in a landmark decision delivered at the end of March, has ruled that Colorado’s statute…
Read More
Gene Therapy Breakthrough Offers Non-Addictive Path for Chronic Pain Treatment via Brain-Specific Circuit Targeting
A groundbreaking preclinical study has identified a novel gene therapy that directly targets pain-processing regions within the brain, potentially revolutionizing…
Read More
Cellares Raises $257M Series D to Automate Cell Therapy Manufacturing
The burgeoning field of cell and gene therapy, heralded as a revolutionary frontier in medicine, is currently grappling with a…
Read More
Researchers Identify Experimental Strategy to Boost MeCP2 Protein Levels as Potential Therapy for Rett Syndrome
A collaborative research team at the Texas Children’s Duncan Neurological Research Institute (NRI) and Baylor College of Medicine has unveiled…
Read More
Expert Insights Emerge on First Successful Huntington’s Disease Gene Therapy Trial Amidst FDA Challenges
Despite promising clinical outcomes from the first-ever gene therapy trial for Huntington’s Disease (HD), a leading expert involved in the…
Read More
Bugs deliver drugs: weaponizing bacteria to target colorectal cancer therapy
A groundbreaking scientific endeavor, spearheaded by a collaborative team of researchers from Baylor University (TX, USA), Texas Tech University Health…
Read More
